APA (7th ed.) Citation

Schmid, U., Weber, B., Sarr, C., & Freiwald, M. (2021). Exposure–safety analyses of nintedanib in patients with chronic fibrosing interstitial lung disease. BMC pulmonary medicine, 21(1), 1-13. https://doi.org/10.1186/s12890-021-01598-0

Chicago Style (17th ed.) Citation

Schmid, Ulrike, Benjamin Weber, Celine Sarr, and Matthias Freiwald. "Exposure–safety Analyses of Nintedanib in Patients with Chronic Fibrosing Interstitial Lung Disease." BMC Pulmonary Medicine 21, no. 1 (2021): 1-13. https://doi.org/10.1186/s12890-021-01598-0.

MLA (9th ed.) Citation

Schmid, Ulrike, et al. "Exposure–safety Analyses of Nintedanib in Patients with Chronic Fibrosing Interstitial Lung Disease." BMC Pulmonary Medicine, vol. 21, no. 1, 2021, pp. 1-13, https://doi.org/10.1186/s12890-021-01598-0.